September 23, 2024 10:48 AM EDT

Context makes a T cell engager deal; Ginkgo Bioworks backers have a new SPAC

Plus, news about Longevity Biomedical, Sensorion, Teva and Bristol Myers Squibb:

Context Therapeutics buys a T cell engager: The biotech will

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Con­text makes a T cell en­gager deal; Gink­go Bioworks back­ers have a new SPAC